155 related articles for article (PubMed ID: 9582363)
1. Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides.
Chabry J; Caughey B; Chesebro B
J Biol Chem; 1998 May; 273(21):13203-7. PubMed ID: 9582363
[TBL] [Abstract][Full Text] [Related]
2. In vitro evaluation of the anti-prionic activity of newly synthesized congo red derivatives.
Poli G; Ponti W; Carcassola G; Ceciliani F; Colombo L; Dall'Ara P; Gervasoni M; Giannino ML; Martino PA; Pollera C; Villa S; Salmona M
Arzneimittelforschung; 2003; 53(12):875-88. PubMed ID: 14750496
[TBL] [Abstract][Full Text] [Related]
3. Prion protein conversion in vitro.
Supattapone S
J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
[TBL] [Abstract][Full Text] [Related]
4. Species-independent inhibition of abnormal prion protein (PrP) formation by a peptide containing a conserved PrP sequence.
Chabry J; Priola SA; Wehrly K; Nishio J; Hope J; Chesebro B
J Virol; 1999 Aug; 73(8):6245-50. PubMed ID: 10400714
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of interactions and interconversions of prion protein isoforms by peptide fragments from the C-terminal folded domain.
Horiuchi M; Baron GS; Xiong LW; Caughey B
J Biol Chem; 2001 May; 276(18):15489-97. PubMed ID: 11279046
[TBL] [Abstract][Full Text] [Related]
6. Molecular properties of complexes formed between the prion protein and synthetic peptides.
Kaneko K; Wille H; Mehlhorn I; Zhang H; Ball H; Cohen FE; Baldwin MA; Prusiner SB
J Mol Biol; 1997 Jul; 270(4):574-86. PubMed ID: 9245588
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines.
Caughey WS; Raymond LD; Horiuchi M; Caughey B
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12117-22. PubMed ID: 9770449
[TBL] [Abstract][Full Text] [Related]
8. Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier.
Kocisko DA; Priola SA; Raymond GJ; Chesebro B; Lansbury PT; Caughey B
Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3923-7. PubMed ID: 7732006
[TBL] [Abstract][Full Text] [Related]
9. N-terminal truncation of prion protein affects both formation and conformation of abnormal protease-resistant prion protein generated in vitro.
Lawson VA; Priola SA; Wehrly K; Chesebro B
J Biol Chem; 2001 Sep; 276(38):35265-71. PubMed ID: 11466311
[TBL] [Abstract][Full Text] [Related]
10. Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity.
Dirikoc S; Priola SA; Marella M; Zsürger N; Chabry J
J Neurosci; 2007 Sep; 27(36):9537-44. PubMed ID: 17804615
[TBL] [Abstract][Full Text] [Related]
11. Effects of FlAsH/tetracysteine (TC) Tag on PrP proteolysis and PrPres formation by TC-scanning.
Taguchi Y; Hohsfield LA; Hollister JR; Baron GS
Chembiochem; 2013 Sep; 14(13):1597-610, 1510. PubMed ID: 23943295
[TBL] [Abstract][Full Text] [Related]
12. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
[TBL] [Abstract][Full Text] [Related]
13. Identification of the prion protein allotypes which accumulate in the brain of sporadic and familial Creutzfeldt-Jakob disease patients.
Silvestrini MC; Cardone F; Maras B; Pucci P; Barra D; Brunori M; Pocchiari M
Nat Med; 1997 May; 3(5):521-5. PubMed ID: 9142120
[TBL] [Abstract][Full Text] [Related]
14. The use of monoclonal antibody epitopes for tagging PrP in conversion experiments.
Vorberg I; Pfaff E; Groschup MH
Arch Virol Suppl; 2000; (16):285-90. PubMed ID: 11214932
[TBL] [Abstract][Full Text] [Related]
15. Conformational change, aggregation and fibril formation induced by detergent treatments of cellular prion protein.
Xiong LW; Raymond LD; Hayes SF; Raymond GJ; Caughey B
J Neurochem; 2001 Nov; 79(3):669-78. PubMed ID: 11701770
[TBL] [Abstract][Full Text] [Related]
16. Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers.
Horiuchi M; Priola SA; Chabry J; Caughey B
Proc Natl Acad Sci U S A; 2000 May; 97(11):5836-41. PubMed ID: 10811921
[TBL] [Abstract][Full Text] [Related]
17. Conformational transitions in peptides containing two putative alpha-helices of the prion protein.
Zhang H; Kaneko K; Nguyen JT; Livshits TL; Baldwin MA; Cohen FE; James TL; Prusiner SB
J Mol Biol; 1995 Jul; 250(4):514-26. PubMed ID: 7542350
[TBL] [Abstract][Full Text] [Related]
18. A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells.
Priola SA; Chesebro B
J Virol; 1995 Dec; 69(12):7754-8. PubMed ID: 7494285
[TBL] [Abstract][Full Text] [Related]
19. In situ formation of protease-resistant prion protein in transmissible spongiform encephalopathy-infected brain slices.
Bessen RA; Raymond GJ; Caughey B
J Biol Chem; 1997 Jun; 272(24):15227-31. PubMed ID: 9182546
[TBL] [Abstract][Full Text] [Related]
20. Copper (II) ions potently inhibit purified PrPres amplification.
Orem NR; Geoghegan JC; Deleault NR; Kascsak R; Supattapone S
J Neurochem; 2006 Mar; 96(5):1409-15. PubMed ID: 16417569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
